A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/00 (2006.01) A61K 38/16 (2006.01) A61K 38/22 (2006.01) A61K 45/00 (2006.01) C07K 7/00 (2006.01) C07K 14/575 (2006.01) A61K 9/00 (2006.01)
Patent
CA 2487269
Novel exendin and exendin agonist compound formulations and dosages and methods of administration thereof are provided. These compositions and methods are useful in treating diabetes and conditions that would be benefited by lowering plasma glucose or delaying and/or slowing gastric emptying or inhibiting food intake.
L'invention concerne une nouvelle exendine et des formulations de composés agonistes de l'exendine, ainsi que des posologies et des procédés d'administration associés. Ces compositions et procédés sont utiles dans le traitement des diabètes et des états pour lesquels une réduction de la glycémie veineuse ou un retard et/ou diminution de la vidange gastrique ou une inhibition de la ration alimentaire pourraient être bénéfiques.
Kolterman Orville G.
Young Andrew A.
Amylin Pharmaceuticals Inc.
Smart & Biggar
LandOfFree
Novel exendin agonist formulations and methods of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel exendin agonist formulations and methods of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel exendin agonist formulations and methods of... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1941659